antibacterial activity antibacterial activity standard
play

ANTIBACTERIAL ACTIVITY Antibacterial activity: Standard drugs 246 - PDF document

Jan 30, 2023 •369 likes •447 views

Graphical Presentation of Antimicrobial Activity ANTIBACTERIAL ACTIVITY Antibacterial activity: Standard drugs 246 Graphical Presentation of Antimicrobial Activity 247 Graphical Presentation of Antimicrobial Activity 248 Graphical

  1. Graphical Presentation of Antimicrobial Activity ANTIBACTERIAL ACTIVITY Antibacterial activity: Standard drugs 246

  2. Graphical Presentation of Antimicrobial Activity 247

  3. Graphical Presentation of Antimicrobial Activity 248

  4. Graphical Presentation of Antimicrobial Activity ANTIFUNGAL ACTIVITY Antifungal activity: Standard drugs 249

  5. Graphical Presentation of Antimicrobial Activity 250

  6. Graphical Presentation of Antimicrobial Activity 251

Recommend

More recommend

1 Macrolide 1 antibacterial activity antibacterial activity Macrolide 2 in bacteria 2 without

1 Macrolide 1 antibacterial activity antibacterial activity Macrolide 2 in bacteria 2 without

1 Macrolide 1 antibacterial activity antibacterial activity Macrolide 2 in bacteria 2 without resistance without resistance in bacteria mechanisms to to macrolide antibiotics macrolide antibiotics mechanisms 1 azithromycin, 1 ,

353 views • 9 slides
Outline Outline Introduction Objective Materials and Methods Results and Discussion Summary

Outline Outline Introduction Objective Materials and Methods Results and Discussion Summary

Oral Presentation CRDC 5 22/07/54 ANTIBACTERIAL ACTIVITY OF ANTIBACTERIAL ACTIVITY OF THE ESSENTIAL OIL FROM THE ESSENTIAL OIL FROM Persicaria odorata LEAVES Persicaria odorata LEAVES Pramono Sasongko Faculty of Agriculture Technology,

280 views • 15 slides
Antibacterial activity of zinc(II) and copper(II) terpyridine complexes Tanja Soldatovi 1, *,

Antibacterial activity of zinc(II) and copper(II) terpyridine complexes Tanja Soldatovi 1, *,

Antibacterial activity of zinc(II) and copper(II) terpyridine complexes Tanja Soldatovi 1, *, Enisa Selimovi 1 , and Braho Li ina 2 1 Department of Chemical-Technological Science, State University of Novi Pazar, Vuka Karadia bb, 36300

708 views • 9 slides
Antibacterial and Antifungal Activity of Selected Styrylquinoline Derivatives Hana Michnova 1,2,

Antibacterial and Antifungal Activity of Selected Styrylquinoline Derivatives Hana Michnova 1,2,

Antibacterial and Antifungal Activity of Selected Styrylquinoline Derivatives Hana Michnova 1,2, *, Sarka Pospisilova 1,2 , Ewelina Spaczynska 3 , Wioleta Cieslik 3 , Alois Cizek 2 , Robert Musiol 3 and Josef Jampilek 1 1 Department of

177 views • 14 slides
antioxidant, antibacterial and antifungal activity of commercial Macedonian cold-pressed oils

antioxidant, antibacterial and antifungal activity of commercial Macedonian cold-pressed oils

Workshop From Molecules to Functionalised Materials Ohrid, Macedonia 2015 The impact of chemical composition on the antioxidant, antibacterial and antifungal activity of commercial Macedonian cold-pressed oils Sanja Kostadinovi

478 views • 23 slides
Antibacterial and anti-biofilm activity of quinazolinone derived Schiff base and its Cu(II)

Antibacterial and anti-biofilm activity of quinazolinone derived Schiff base and its Cu(II)

Antibacterial and anti-biofilm activity of quinazolinone derived Schiff base and its Cu(II) complex rka Pospilov 1* , Jana Hricovniov 2 , Alois ek 3 , Zuzana Hricovniov 4 , Josef Jamplek 1 1 Division of Biologically Active

908 views • 12 slides
ANTIBACTERIAL ACTIVITY OF APIGENIN, LUTEOLIN, AND THEIR C-GLUCOSIDES Tomasz M. Karpiski 1 *,

ANTIBACTERIAL ACTIVITY OF APIGENIN, LUTEOLIN, AND THEIR C-GLUCOSIDES Tomasz M. Karpiski 1 *,

ANTIBACTERIAL ACTIVITY OF APIGENIN, LUTEOLIN, AND THEIR C-GLUCOSIDES Tomasz M. Karpiski 1 *, Artur Adamczak 2 , and Marcin Oarowski 3 Tomasz M. Karpiski 1 *, Artur Adamczak 2 , and Marcin Oarowski 3 1 Department of Medical Microbiology,

376 views • 8 slides
Efficiency Efficiency and and Antibacterial Antibacterial Strength Strength of of SmartCoat

Efficiency Efficiency and and Antibacterial Antibacterial Strength Strength of of SmartCoat

Detoxification Detoxification Efficiency Efficiency and and Antibacterial Antibacterial Strength Strength of of SmartCoat SmartCoat CHARACTERISTIC OF SMARTCOAT Particle Morphology By Transmission Electron Microscopy New nano

558 views • 26 slides
Antibacterial Drug Development an FDA Perspective Ed Cox, MD MPH Director, Office of

Antibacterial Drug Development an FDA Perspective Ed Cox, MD MPH Director, Office of

Antibacterial Drug Development an FDA Perspective Ed Cox, MD MPH Director, Office of Antimicrobial Products OND/CDER/FDA 1 1 Background Development of new antibacterial agents is essential to meet patient needs Need therapies to

104 views • 8 slides
2012 Addendum to the EU Guideline on Antibacterial Agents EMA Workshop on development of new

2012 Addendum to the EU Guideline on Antibacterial Agents EMA Workshop on development of new

2012 Addendum to the EU Guideline on Antibacterial Agents EMA Workshop on development of new antibacterial medicines October 2012 Presented by: Mair Powell Rapporteur An agency of the European Union Current guidance Guideline on

460 views • 43 slides
The paediatric Addendum to the antibacterial agents guideline Maria Jesus Fernandez Cortizo

The paediatric Addendum to the antibacterial agents guideline Maria Jesus Fernandez Cortizo

The paediatric Addendum to the antibacterial agents guideline Maria Jesus Fernandez Cortizo IDWP/PDCO EMA Workshop on development of antibacterial medicinal products for paediatric patients London, 21-22 June 2018 Agenda Overview of

148 views • 14 slides
Modernizing Antibacterial Drug Development and Promoting Stewardship Engelberg Center for Health

Modernizing Antibacterial Drug Development and Promoting Stewardship Engelberg Center for Health

Modernizing Antibacterial Drug Development and Promoting Stewardship Engelberg Center for Health Care Reform The Brookings Institution Washington, D.C. February 7, 2014 Modernizing Antibacterial Drug Development and Promoting Stewardship

331 views • 30 slides
Antibacterial and Antibiofilm Screening of New Platinum(IV) Complexes with some S-Alkyl

Antibacterial and Antibiofilm Screening of New Platinum(IV) Complexes with some S-Alkyl

Antibacterial and Antibiofilm Screening of New Platinum(IV) Complexes with some S-Alkyl Derivatives of Thiosalicylic Acid Marina Mijajlovi 1 , Sava Vasi 2 , Ivana Radojevi 2, *, Jovana Maksimovi 2 , Ljiljana omi 2 , M ilo Nikol i

435 views • 11 slides
Synthesis of 5-BromoVerongamine, an Antibacterial Dibromotyrosine Metabolite from Pseudoceratina

Synthesis of 5-BromoVerongamine, an Antibacterial Dibromotyrosine Metabolite from Pseudoceratina

[c002] Synthesis of 5-BromoVerongamine, an Antibacterial Dibromotyrosine Metabolite from Pseudoceratina sponge Suresh K. Kottakota a , J. Jonathan Harburn a* , Anthony OShaughnessy a , Mark Gray a , Philppos Konstanidis a , Davis E. Yakubu a a

436 views • 7 slides
1 Depto. Farmacia, CRIDECIT, FCNyCS, UNPSJB, Km. 4, (9000), Comodoro Rivadavia, Chubut. 2 Depto. de

1 Depto. Farmacia, CRIDECIT, FCNyCS, UNPSJB, Km. 4, (9000), Comodoro Rivadavia, Chubut. 2 Depto. de

SUPRAMOLECULAR COMPLEX OF NORFLOXACIN AND SULFAMETHOXAZOLE: SYNTHESIS, CHARACTERIZATION AND EVALUATION OF THE ANTIBACTERIAL ACTIVITY Avila CD 1 , Ayala Gmez R, 1 Becerra MC 2 , Mazzieri MR 2 , Pinto Vitorino G 1 . 1 Depto. Farmacia, CRIDECIT,

1.13k views • 15 slides
Vitamin C and E contents, antioxidant, antibacterial and antiproliferative activities of Citrus

Vitamin C and E contents, antioxidant, antibacterial and antiproliferative activities of Citrus

Vitamin C and E contents, antioxidant, antibacterial and antiproliferative activities of Citrus suhuiensis peel Wan Zain 1 , Nurul Mamat 2 , Raja Sharin 1 , Noor Jumahat 1 , Jamal Houssaini 1 and Jesmine Khan 1* 1 Faculty of Medicine, Universiti

445 views • 15 slides
OUTLINE ACTIVITY: Standard interpretation of behaviours, HO ACTIVITY: The problem People with FASD

OUTLINE ACTIVITY: Standard interpretation of behaviours, HO ACTIVITY: The problem People with FASD

OUTLINE ACTIVITY: Standard interpretation of behaviours, HO ACTIVITY: The problem People with FASD have strengths Take Care of Yourself What is FASD? Definition Recognizes that this disorder encompasses a range of diagnoses and challenges for

286 views • 11 slides
The EU Regulatory Framework for New Antibacterial Agents Presented by: Mair Powell CHMP

The EU Regulatory Framework for New Antibacterial Agents Presented by: Mair Powell CHMP

The EU Regulatory Framework for New Antibacterial Agents Presented by: Mair Powell CHMP Infectious Diseases Working Party (IDWP) An agency of the European Union Specific guidelines to be discussed CPMP/ EWP/ 558/ 95 Rev 2 January 2012

297 views • 15 slides
of quinoline-antimicrobial peptide conjugates as antibacterial drugs Pierre Laumaill 1* ,

of quinoline-antimicrobial peptide conjugates as antibacterial drugs Pierre Laumaill 1* ,

Synthesis, biological evaluation and membranotropic properties of quinoline-antimicrobial peptide conjugates as antibacterial drugs Pierre Laumaill 1* , Alexandra Dassonville-Klimpt 1 , Sophie Da Nascimento 1 , Catherine Mulli 1 , Franois

517 views • 23 slides
Development of Antibacterial Drugs for Children U.S. FDA Perspective John Farley MD MPH

Development of Antibacterial Drugs for Children U.S. FDA Perspective John Farley MD MPH

General Considerations for the Development of Antibacterial Drugs for Children U.S. FDA Perspective John Farley MD MPH Deputy Director Office of Anti-Microbial Products CDER FDA 21 June 2018 General Principles Pediatric patients

345 views • 18 slides
Disclosures Grant/funding from: Antibacterial Research Leadership Group (NIH), Infectious

Disclosures Grant/funding from: Antibacterial Research Leadership Group (NIH), Infectious

Disclosures Grant/funding from: Antibacterial Research Leadership Group (NIH), Infectious Diseases Society of America Consultant: Actelion, Genentech Cl Clostridium m difficile difficulties Sarah Doernberg, MD, MAS Assistant professor

278 views • 16 slides
STUDYING NEONATES WORKSHOP ON DEVELOPMENT OF ANTIBACTERIAL PRODUCTS FOR PAEDIATRIC PATIENTS

STUDYING NEONATES WORKSHOP ON DEVELOPMENT OF ANTIBACTERIAL PRODUCTS FOR PAEDIATRIC PATIENTS

STUDYING NEONATES WORKSHOP ON DEVELOPMENT OF ANTIBACTERIAL PRODUCTS FOR PAEDIATRIC PATIENTS European Medicines Agency London, United Kingdom 21-06-2018 Matthew G. Johnson, MD Clinical Director, Infectious Diseases This is a joint industry

455 views • 14 slides
SYNTHESIS, ANTIBACTERIAL AND ANTIFUNGAL ACTIVITIES OF HYBRID MOLECULES BASED ON ALZHEIMER

SYNTHESIS, ANTIBACTERIAL AND ANTIFUNGAL ACTIVITIES OF HYBRID MOLECULES BASED ON ALZHEIMER

SYNTHESIS, ANTIBACTERIAL AND ANTIFUNGAL ACTIVITIES OF HYBRID MOLECULES BASED ON ALZHEIMER DISEASE DRUGS AND BEARING AN AMINO ACID FRAGMENT RADOSLAV CHAYROV, ALEKSANDRA TENCHEVA, HRISTINA SBIRKOVA-DIMITROVA, BORIS SHIVACHEV, ANNA KUJUMDZIEVA,

318 views • 15 slides
Non-Inferiority (NI) Clinical Trials: Some Key Considerations in Antibacterial Drug Studies May

Non-Inferiority (NI) Clinical Trials: Some Key Considerations in Antibacterial Drug Studies May

Brookings-FDA Workshop Non-Inferiority (NI) Clinical Trials: Some Key Considerations in Antibacterial Drug Studies May 9, 2012 Thomas R. Fleming, Ph.D. Professor of Biostatistics University of Washington Fleming TR. Statistics in Medicine ,

532 views • 17 slides